Polymeric Nanoparticles for Dna Vaccine-Based Cancer Immunotherapy: A Review Publisher Pubmed



Danaeifar M¹ ; Negahdari B¹ ; Eslam HM² ; Zare H³ ; Ghanaat M⁴ ; Koushali SS³ ; Malekshahi ZV¹
Source: Biotechnology Letters Published:2023

Abstract

Cancer is one of the leading causes of death and mortality in the world. There is an essential need to develop new drugs or therapeutic approaches to manage treatment-resistant cancers. Cancer immunotherapy is a type of cancer treatment that uses the power of the body’s immune system to prevent, control, and eliminate cancer. One of the materials used as a vaccine in immunotherapy is DNA. The application of polymeric nanoparticles as carriers for DNA vaccines could be an effective therapeutic approach to activate immune responses and increase antigen presentation efficiency. Various materials have been used as polymeric nanoparticles, including: chitosan, poly (lactic-co-glycolic acid), Polyethylenimine, dendrimers, polypeptides, and polyesters. Application of these polymer nanoparticles has several advantages, including increased vaccine delivery, enhanced antigen presentation, adjuvant effects, and more sustainable induction of the immune system. Besides many clinical trials and commercial products that were developed based on polymer nanoparticles, there is still a need for more comprehensive studies to increase the DNA vaccine efficiency in cancer immunotherapy using this type of carrier. © 2023, The Author(s), under exclusive licence to Springer Nature B.V.